This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Aelis Farma, National Institute of Health and Medical Research, Universitë De Bordeaux. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3 
2 out of 1,853 
2 out of 228 
Years Active: 2022-2025
Title: Arnau Busquet-Garcia: Innovator in Cannabinoids-Related Disorders
Introduction
Arnau Busquet-Garcia is a notable inventor based in Bordeaux, France. He is recognized for his contributions in the field of cannabinoids-related disorders through innovative pharmaceutical formulations.
Latest Patents
Busquet-Garcia holds one patent for his invention titled "3β-(4-methoxybenzyloxy)pregn-5-en-20-one." This invention relates to a specific pregnenolone derivative intended for treating cannabinoids-related disorders. More specifically, it encompasses a compound of Formula (I), which presents a potential therapeutic avenue for patients suffering from such disorders.
Career Highlights
Throughout his career, Arnau Busquet-Garcia has been associated with distinguished companies such as Aelis Farma and the Institut National de la Santé et de la Recherche Médicale. His experience in these organizations underscores his commitment to advancing medical science and improving treatment options.
Collaborations
During his professional journey, Busquet-Garcia has collaborated with other prominent individuals in his field, including Pier Vincenzo Piazza and Sandy Fabre. These collaborative efforts have enhanced the development of innovative solutions in the realm of cannabinoids and their related ailments.
Conclusion
Arnau Busquet-Garcia exemplifies the spirit of innovation in the healthcare sector. His patent and contributions to the treatment of cannabinoids-related disorders pave the way for future advancements in medicine, showcasing the importance of research and development in enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile